- Home
- NNVC vs EKSO Comparison
NNVC vs EKSO Comparison
Compare NNVC & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNVC
- EKSO
- Stock Information
- Founded
- NNVC 2005
- EKSO 2005
- Country
- NNVC United States
- EKSO United States
- Employees
- NNVC N/A
- EKSO N/A
- Industry
- NNVC Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- NNVC Health Care
- EKSO Health Care
- Exchange
- NNVC Nasdaq
- EKSO Nasdaq
- Market Cap
- NNVC 17.7M
- EKSO 19.1M
- IPO Year
- NNVC N/A
- EKSO N/A
- Fundamental
- Price
- NNVC $1.35
- EKSO $0.74
- Analyst Decision
- NNVC Strong Buy
- EKSO Strong Buy
- Analyst Count
- NNVC 1
- EKSO 2
- Target Price
- NNVC $6.50
- EKSO $5.50
- AVG Volume (30 Days)
- NNVC 130.2K
- EKSO 102.7K
- Earning Date
- NNVC 11-22-2024
- EKSO 10-28-2024
- Dividend Yield
- NNVC N/A
- EKSO N/A
- EPS Growth
- NNVC N/A
- EKSO N/A
- EPS
- NNVC N/A
- EKSO N/A
- Revenue
- NNVC N/A
- EKSO $17,682,000.00
- Revenue This Year
- NNVC N/A
- EKSO $1.11
- Revenue Next Year
- NNVC N/A
- EKSO $38.63
- P/E Ratio
- NNVC N/A
- EKSO N/A
- Revenue Growth
- NNVC N/A
- EKSO 4.12
- 52 Week Low
- NNVC $1.00
- EKSO $0.72
- 52 Week High
- NNVC $3.59
- EKSO $3.13
- Technical
- Relative Strength Index (RSI)
- NNVC 42.61
- EKSO 29.37
- Support Level
- NNVC $1.44
- EKSO $0.74
- Resistance Level
- NNVC $1.58
- EKSO $0.92
- Average True Range (ATR)
- NNVC 0.08
- EKSO 0.07
- MACD
- NNVC -0.01
- EKSO -0.01
- Stochastic Oscillator
- NNVC 26.79
- EKSO 7.70
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.